1. Cell Biology
  2. Medicine

Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open label interventional study

  1. Avner Ehrlich
  2. Konstantinos Ioannidis
  3. Makram Nasar
  4. Ismaeel Abu Alkian
  5. Yuval Daskal
  6. Nofar Atari
  7. Limor Kliker
  8. Nir Rainy
  9. Matan Hofree
  10. Sigal Shafran Tikva
  11. Inbal Houri
  12. Arrigo Cicero
  13. Chiara Pavanello
  14. Cesare R Sirtori
  15. Jordana B Cohen
  16. Julio A. Chirinos
  17. Lisa Deutsch
  18. Merav Cohen
  19. Amichai Gottlieb
  20. Adina Bar-Chaim
  21. Oren Shibolet
  22. Michal Mandelboim
  23. Shlomo Maayan
  24. Yaakov Nahmias  Is a corresponding author
  1. Hebrew University of Jerusalem, Israel
  2. Barzilai Medical Center, Israel
  3. Sheba Medical Center, Israel
  4. Shamir (Assaf Harofeh) Medical Center, Israel
  5. Broad Institute, United States
  6. Jerusalem College of Technology, Israel
  7. Tel Aviv Sourasky Medical Center, Israel
  8. Policlinico S.Orsola-Malpighi, Italy
  9. Università degli Studi di Milano, Italy
  10. Niguarda Hospital, Italy
  11. University of Pennsylvania, United States
  12. BioStats Statistical Consulting Ltd, Israel
https://doi.org/10.7554/eLife.79946
Share this article
Cite this article
  1. Avner Ehrlich
  2. Konstantinos Ioannidis
  3. Makram Nasar
  4. Ismaeel Abu Alkian
  5. Yuval Daskal
  6. Nofar Atari
  7. Limor Kliker
  8. Nir Rainy
  9. Matan Hofree
  10. Sigal Shafran Tikva
  11. Inbal Houri
  12. Arrigo Cicero
  13. Chiara Pavanello
  14. Cesare R Sirtori
  15. Jordana B Cohen
  16. Julio A. Chirinos
  17. Lisa Deutsch
  18. Merav Cohen
  19. Amichai Gottlieb
  20. Adina Bar-Chaim
  21. Oren Shibolet
  22. Michal Mandelboim
  23. Shlomo Maayan
  24. Yaakov Nahmias
(2023)
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open label interventional study
eLife 12:e79946.
https://doi.org/10.7554/eLife.79946
  2. Download BibTeX
  3. Download .RIS

Peer review process

This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.

History

  1. Version of Record published
  2. Accepted Manuscript published
  3. Accepted
  4. Received
  5. Preprint posted

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Avner Ehrlich
  2. Konstantinos Ioannidis
  3. Makram Nasar
  4. Ismaeel Abu Alkian
  5. Yuval Daskal
  6. Nofar Atari
  7. Limor Kliker
  8. Nir Rainy
  9. Matan Hofree
  10. Sigal Shafran Tikva
  11. Inbal Houri
  12. Arrigo Cicero
  13. Chiara Pavanello
  14. Cesare R Sirtori
  15. Jordana B Cohen
  16. Julio A. Chirinos
  17. Lisa Deutsch
  18. Merav Cohen
  19. Amichai Gottlieb
  20. Adina Bar-Chaim
  21. Oren Shibolet
  22. Michal Mandelboim
  23. Shlomo Maayan
  24. Yaakov Nahmias
(2023)
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open label interventional study
eLife 12:e79946.
https://doi.org/10.7554/eLife.79946

Share this article

https://doi.org/10.7554/eLife.79946